{"name":"Blueberry Therapeutics","slug":"blueberry-therapeutics","ticker":"","exchange":"","domain":"","description":"Blueberry Therapeutics is a biotechnology company focused on developing innovative treatments for various diseases. The company has a pipeline of three drug candidates, all in Phase 2 clinical trials, targeting significant unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQd1dBVzlnQUsxWEJMSjNnSDFHZHBwSldGR3g0V2R6a1dOTldka09mOUFRM0ZvTlV4enlvQmItbGljWWxQODk1ejVJbEd6Vjc3QzNTWUlUUUE3UzhManpCZVEwZzNUMGVUZGgxVXkyLWh4OTFLVC1jWlpnMjBQQWRhWHR0TkRHWHl0MFRjY1RJQQ?oc=5","date":"2024-10-22","type":"pipeline","source":"Labiotech.eu","summary":"Eight nanotechnology companies to watch out for - Labiotech.eu","headline":"Eight nanotechnology companies to watch out for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBwRGNSSUpkekxCN3lvZmRKZkotNzlLeExpMUVNNzJhUEk0Y0xHZ3VGaldaWVAtYTVYTW8ySnVFRDdJajZjay03NkpjRU5BVXJqc0p3UjBtS0EyRHFUOGJSekNjVjZCcV9Iejlha1gzQ3ZWMk5QQXlFeDNR?oc=5","date":"2023-02-03","type":"pipeline","source":"Market.us","summary":"Dermatophytic Onychomycosis Treatment Market CAGR Of 8.46% - Market.us","headline":"Dermatophytic Onychomycosis Treatment Market CAGR Of 8.46%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOM2l1V0NpNkFFaG9KbTR4dnBMTWtVZFMxRjEyUjg1SHlTRVRaVHd4UVRfVk9wdUN0VEhpQkxUX0lhc2xIRjJJSnl0ZVo1X2lBV1BBcVZxUnoxSkpCSUdyRDZ4a0dXSEFDWmxHTzBfcG84NmZZTGVtLWpYajFMN0xibDdRbjlBa3ZLcjkzUzRHdXJQNGlrS1VRZWVuTFJ2MEdnMU03VXZRVDM5Rkx6YWxZOEI4YzF1WGowenY4d0hMS0VFbnNJRDl3?oc=5","date":"2021-08-26","type":"pipeline","source":"European Pharmaceutical Review","summary":"Improvements in skin and nail drug delivery using nano formulations - European Pharmaceutical Review","headline":"Improvements in skin and nail drug delivery using nano formulations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPTVl0WWl0RWJFRW8tVGhvNThTZ2ZvWWxHcDhQbGdVN1BtQ25GTU5iMGhPcGhKTkw3N2tDeVZfbGxQVU43aU00bXlkTEFfNVlPQlZKNGp5R3l6RjdTdVd0N3BDQWVzYjFhRGR3WVFPSUl1OXBwREo1U1F4T0NyR2dYaDlSWExGWkVySjN1SUgtSk4zeFM0QWFIcU9WLUNETW5BMGE3RlZYSnppZG0tVkstQQ?oc=5","date":"2020-09-24","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy - Genetic Engineering and Biotechnology News","headline":"Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOd2FPanc1T3VDanFzMHVTS3dIZThZOHgwVDNBd2xGOWY1UmF4UV9kTDlDanJ4ZTRMVDVocDJHR3FxSVhCTmxQMVlPb0VVMXA1aWhhSVNvaTIxSnBnWnVJVVhyekJneUwzUWZQT2VUT1Vib0tjejZnQnI4RXJiWjNiLWYxM080ZmtEaWp3NGVVNG05WkE1cFZvZTFCR29EOTkxNFhBeGJUQnFPakswalpRbTBYaFc?oc=5","date":"2020-02-03","type":"pipeline","source":"PharmaTimes","summary":"Blueberry Therapeutics appoints Dr Adrian Howd to board of directors - PharmaTimes","headline":"Blueberry Therapeutics appoints Dr Adrian Howd to board of directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9NNWhtZ2NybmpNV0drV3VFdzBVQ096MjRKNUZ6emE4c0tHc0JGT1g4YnU3ZTNNWUdfYXdMZnduc1F4czYwNmRLZHltYV9WdFpmUW1RelV6bEhPQ09ZRFpEelBR?oc=5","date":"2019-01-10","type":"pipeline","source":"Nanalyze","summary":"Nano Drug Delivery for Cancer, Dermatology, and Pain - Nanalyze","headline":"Nano Drug Delivery for Cancer, Dermatology, and Pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOX2VOWm8tMHBCVWFSS25aNHEwLUc4RTZ1TTdDb3dTeTE2NlZaX2pUMGlXel81X2xJc3B6dUtad0ZUc1ZuVDdUaTZ5bUp5ZXZPQzJ2azBfM1E4Z19XSUZSV29XcDNoZTVsQzF0aHE5WUJuQjExYjJVQXlXX1NRU3RqMlpXOHJDMFdLOWp1Q0NCTTAzR2lPcFE?oc=5","date":"2016-08-04","type":"pipeline","source":"Insider Media Ltd","summary":"Alderley Park transformation ‘ahead of schedule’ - Insider Media Ltd","headline":"Alderley Park transformation ‘ahead of schedule’","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2013-05-08","type":"pipeline","source":"Manchester Evening News","summary":"AstraZeneca's Alderley Park site boosted with three new tenants - Manchester Evening News","headline":"AstraZeneca's Alderley Park site boosted with three new tenants","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}